AVN-944
| CAS No. | 297730-17-7 | Cat. No. | BCP23877 |
| Name | AVN-944 | ||
| Synonyms | AVN 944; AVN944; VX944; VX 944; VX-944; | ||
| Formula | C25H27N5O5 | M. Wt | 477.51 |
| Description | AVN-944 (VX-944) is an orally available, synthetic small molecule with potential antineoplastic activity. AVN944 inhibits inosine monosphosphate dehydrogenase (IMPDH), an enzyme involved in the de novo synthesis of guanosine triphosphate (GTP), a purine molecule required for DNA and RNA synthesis. Inhibition of IMPDH deprives cancer cells of GTP, resulting in disruption of DNA and RNA synthesis, inhibition of cell proliferation, and the induction of apoptosis. AVN944 appears to have a selective effect on cancer cells in that deprivation of GTP in normal cells results in a temporary slowing of cell growth only. IMPDH is overexpressed in some cancer cells, particularly in hematological malignancies. | ||
| Pathways | Protease/Metabolic Enzyme Cell Cycle/DNA Damage Apoptosis Pathway | ||
| Targets | DNA/RNA Synthesis Caspase Bcl2 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.